Insider Transactions Reported by 25 Insiders of PROKIDNEY CORP.

Symbol
PROK on Nasdaq
Location
Winston Salem, NC

Key facts

  • PROK - PROKIDNEY CORP. has 25 insiders with reported activity on this page.
  • Net insider value flow over the last year: -$1,884,577.
  • Recent transaction rows are available for direct filing-level review.

Change

  • Buy value: ; sell value: $1,884,577.
  • Net share flow: -757,162.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$1,884,577.

Buys

$0

Shares: 0

Insiders: 0

Sells

$1,884,577

Shares: 757,162

Insiders: 1

Net

-$1,884,577

Shares: -757,162

Insiders: -1

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 757,162 $0 $1,884,577 -$1,884,577
9-12 0 0 $0 $0 $0

Top shareholders of PROKIDNEY CORP. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.

13D/G 3/4/5 13F
Lead reported holder
36% from 13D/G
Large-stake signal
13D/G evidence reports 36%
Evidence coverage
50 holder rows
Latest evidence as of 28 Apr 2026. Highest disclosed value: $132,052,942.
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder Evidence Ownership % Position 12M Net Δ As of
Tolerantia, LLC
13D/G
36%
$93,004,165
106,901,339 shares
-$3,326,877 03 Jun 2025
Control Empresarial de Capitales S.A. de C.V.
13D/G 3/4/5
Other*, 10%+ Owner
36%
$132,052,942
73,842,723 shares
$0 28 Apr 2026
MORGAN STANLEY
13D/G 13F
Company
6%
$19,510,759
8,519,982 shares
$0 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
1.4%
from 13D/G
$2,482,938
1,387,116 shares
31 Mar 2026
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
6%
$22,090,866
12,341,266 shares
31 Mar 2026
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
1.1%
$4,066,123
2,271,577 shares
31 Mar 2026
Bleichroeder LP
13F
Company
13F
0.98%
$3,580,000
2,000,000 shares
31 Mar 2026
Artia Global Partners LP
13F
Company
13F
0.88%
$3,234,421
1,806,939 shares
31 Mar 2026
Hennion & Walsh Asset Management, Inc.
13F
Company
13F
0.79%
$2,884,930
1,611,693 shares
31 Mar 2026
Brown University
13F
Company
13F
0.77%
$1,790,000
1,000,000 shares
31 Mar 2026
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.61%
$2,238,921
1,250,794 shares
31 Mar 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.6%
$2,203,520
1,230,409 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
0.56%
$2,053,017
1,146,937 shares
31 Mar 2026
MARSHALL WACE, LLP
13F
Company
13F
0.49%
$1,811,023
1,011,744 shares
31 Mar 2026
BANK OF AMERICA CORP /DE/
13F
Company
13F
0.37%
$1,348,607
753,412 shares
31 Mar 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
13F
0.31%
$1,123,710
627,771 shares
31 Mar 2026
STATE STREET CORP
13F
Company
13F
0.27%
$996,753
556,845 shares
31 Mar 2026
VANGUARD FIDUCIARY TRUST CO
13F
Company
13F
0.26%
$963,684
538,371 shares
31 Mar 2026
Woodline Partners LP
13F
Company
13F
0.24%
$895,000
500,000 shares
31 Mar 2026
MYDA Advisors LLC
13F
Company
13F
0.21%
$767,507
428,775 shares
31 Mar 2026
GOLDMAN SACHS GROUP INC
13F
Company
13F
0.21%
$755,204
421,902 shares
31 Mar 2026
TWO SIGMA INVESTMENTS, LP
13F
Company
13F
0.17%
$620,024
346,382 shares
31 Mar 2026
UBS Group AG
13F
Company
13F
0.16%
$598,837
334,546 shares
31 Mar 2026
Amundi
13F
Individual
13F
0.14%
$522,157
291,708 shares
31 Mar 2026
JANE STREET GROUP, LLC
13F
Company
13F
0.13%
$473,070
264,285 shares
31 Mar 2026
ExodusPoint Capital Management, LP
13F
Company
13F
0.12%
$455,292
254,353 shares
31 Mar 2026
NORTHERN TRUST CORP
13F
Company
13F
0.12%
$432,428
241,580 shares
31 Mar 2026
Squarepoint Ops LLC
13F
Company
13F
0.1%
$377,882
211,107 shares
31 Mar 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
13F
0.1%
$366,034
204,488 shares
31 Mar 2026
GSA CAPITAL PARTNERS LLP
13F
Company
13F
0.1%
$364,000
203,226 shares
31 Mar 2026
BARCLAYS PLC
13F
Company
13F
0.07%
$261,849
146,284 shares
31 Mar 2026
Virtus Investment Advisers, LLC
13F
Company
13F
0.06%
$220,865
123,388 shares
31 Mar 2026
HRT FINANCIAL LP
13F
Company
13F
0.06%
$212,000
118,981 shares
31 Mar 2026
Voleon Capital Management LP
13F
Company
13F
0.05%
$183,829
102,698 shares
31 Mar 2026
Susquehanna Portfolio Strategies, LLC
13F
Company
13F
0.05%
$174,307
97,378 shares
31 Mar 2026
EntryPoint Capital, LLC
13F
Company
13F
0.04%
$148,323
82,862 shares
31 Mar 2026
OMERS ADMINISTRATION Corp
13F
Company
13F
0.03%
$121,541
67,900 shares
31 Mar 2026
Point72 Asset Management, L.P.
13F
Company
13F
0.03%
$117,385
65,578 shares
31 Mar 2026
Brevan Howard Capital Management LP
13F
Company
13F
0.03%
$114,834
64,153 shares
31 Mar 2026
Hudson Bay Capital Management LP
13F
Company
13F
0.03%
$111,130
62,084 shares
31 Mar 2026
Jain Global LLC
13F
Company
13F
0.03%
$91,836
51,305 shares
31 Mar 2026
CITIGROUP INC
13F
Company
13F
0.02%
$88,397
49,384 shares
31 Mar 2026
Diametric Capital, LP
13F
Company
13F
0.02%
$85,610
47,827 shares
31 Mar 2026
Catalyst Funds Management Pty Ltd
13F
Company
13F
0.02%
$85,562
47,800 shares
31 Mar 2026
Jefferies Financial Group Inc.
13F
Company
13F
0.02%
$83,052
46,398 shares
31 Mar 2026
Vanguard Global Advisers, LLC
13F
Company
13F
0.02%
$60,992
34,074 shares
31 Mar 2026
Schonfeld Strategic Advisors LLC
13F
Company
13F
0.02%
$58,791
32,845 shares
31 Mar 2026
Virtus Family Office LLC
13F
Company
13F
0.01%
$49,225
27,500 shares
31 Mar 2026
Tower Research Capital LLC (TRC)
13F
Company
13F
0.01%
$36,586
20,439 shares
31 Mar 2026
Jump Financial, LLC
13F
Company
13F
0.01%
$33,187
18,540 shares
31 Mar 2026

PROKIDNEY CORP. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Pablo G. Legorreta Director, 10%+ Owner $396,228,878 Mixed 03 Jun 2025
Control Empresarial de Capitales S.A. de C.V. Other*, 10%+ Owner $132,052,941 Median 28 Apr 2026
SC Master Holdings, LLC 10%+ Owner $17,374,357 Mixed 11 Jul 2022
Brian Jg Pereira Director $4,270,858 -$1,884,577 -31% Mixed 12 Nov 2025
Aaron Cowen 10%+ Owner $2,143,751 Mixed 11 Jul 2025
Darin J. Weber Chief Regulatory Officer $0 Mixed 01 Mar 2026
Chamath Palihapitiya Former 10% Owner Mixed 19 Nov 2023
SCS Sponsor III LLC Former Director and 10% Owner Mixed 11 Jul 2022
John Maraganore Director Mixed 29 Jun 2023
William F. Doyle Director Mixed 29 May 2025
Libbie Parker McKenzie Chief Medical Officer Mixed 16 Jan 2023
Deepak Jain Chief Operating Officer Mixed 16 Jan 2023
James Coulston Chief Financial Officer Mixed 01 Mar 2026
Santos Jose Ignacio Jimenez Director Mixed 29 May 2025
Uma Sinha Director Mixed 29 May 2025
Bruce Culleton Chief Executive Officer, Director Mixed 01 Mar 2026
Todd C. Girolamo Chief Legal Officer Mixed 01 Mar 2026
Ulrich Peter Alfred Ernst EVP, Technical Operations Mixed 01 Apr 2024
Alan Lotvin Director Mixed 29 May 2025
Jennifer A. Fox Director Mixed 29 May 2025
Timothy Bertram Chief Executive Officer, Director Mixed 16 Jan 2023
Mary Weger Chief People Officer Mixed 16 Jan 2023
James Ryans Chief Financial Officer Mixed 29 Jun 2021
Shoney Katz Director of Research Mixed 29 Jun 2021
Semigran Marc Director Mixed 29 Jun 2021

Recent Insider Transactions by Companies or Individuals for PROKIDNEY CORP.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Control Empresarial de Capitales S.A. de C.V. PROK Class A Common Shares (as defined in Exhibit 99.1 hereto) Conversion of derivative security 588.6% 63,118,645 73,842,723 28 Apr 2026 Direct
Control Empresarial de Capitales S.A. de C.V. PROK Common Units in ProKidney LLC Conversion of derivative security -100% -63,118,645 0 28 Apr 2026 Direct
Control Empresarial de Capitales S.A. de C.V. PROK Class B Common Shares Conversion of derivative security -100% -63,118,645 0 28 Apr 2026 Direct
James Coulston PROK Employee stock option (right to buy) Award 600,000 600,000 01 Mar 2026 Direct
Darin J. Weber PROK Employee stock option (right to buy) Award 400,000 400,000 01 Mar 2026 Direct
Todd C. Girolamo PROK Employee stock option (right to buy) Award 600,000 600,000 01 Mar 2026 Direct
Bruce Culleton PROK Employee stock option (right to buy) Award 3,000,000 3,000,000 01 Mar 2026 Direct
Brian Jg Pereira PROK Class A Common Stock Sale -100% $128,769 $2.37 -54,333 0 13 Nov 2025 Brian J. G. Pereira 2004 Trust
Brian Jg Pereira PROK Class A Common Stock Sale -100% $1,061,293 $2.37 -447,803 0 13 Nov 2025 By Brian J. G. Pereira 2012 Irrevocable Trust
Brian Jg Pereira PROK Class A Common Stock Sale -33.7% $75,152 $2.72 -27,595 54,333 12 Nov 2025 Brian J. G. Pereira 2004 Trust
Brian Jg Pereira PROK Class A Common Stock Sale -33.7% $619,363 $2.72 -227,431 447,803 12 Nov 2025 By Brian J. G. Pereira 2012 Irrevocable Trust
Darin J. Weber PROK Class A Common Stock Sale -100% -103,480 0 08 Jul 2025 Direct
Pablo G. Legorreta PROK Class A Ordinary Shares Other -14.5% -3,823,996 22,617,909 03 Jun 2025 See footnote
Pablo G. Legorreta PROK Class A Ordinary Shares Conversion of derivative security 16.9% 3,823,996 26,441,905 03 Jun 2025 See footnote
Pablo G. Legorreta PROK Common Units in ProKidney LP Conversion of derivative security -4.34% -3,823,996 84,283,430 03 Jun 2025 See footnote
Pablo G. Legorreta PROK Class B Ordinary Shares Conversion of derivative security -4.34% -3,823,996 84,283,430 03 Jun 2025 See footnote
Pablo G. Legorreta PROK Director stock option (right to buy) Award 125,862 125,862 29 May 2025 Direct
Uma Sinha PROK Director stock option (right to buy) Award 125,862 125,862 29 May 2025 Direct
Brian Jg Pereira PROK Director stock option (right to buy) Award 125,862 125,862 29 May 2025 Direct
Santos Jose Ignacio Jimenez PROK Director stock option (right to buy) Award 125,862 125,862 29 May 2025 Direct
Jennifer A. Fox PROK Director stock option (right to buy) Award 125,862 125,862 29 May 2025 Direct
William F. Doyle PROK Director stock option (right to buy) Award 125,862 125,862 29 May 2025 Direct
Alan Lotvin PROK Director stock option (right to buy) Award 125,862 125,862 29 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .